ZHANG JACK Y. (CEO & CHIEF SCIENTIFIC OFFICER) reported 2 transactions at AMPHASTAR PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/7/2026ACC: 0001104659-26-024842
DirectorOfficer10% Owner· CEO & CHIEF SCIENTIFIC OFFICER
Since Mar 2026
-8.20K
Net shares
Net seller
$163.7K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
8.20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.77K
Price / share
$19.96
Trade value
$115.15K
% of position
0.2%
3/4/2026
2.85M→2.84M
Common Stock
Indirect
Shares
−2.43K
Price / share
$19.96
Trade value
$48.54K
% of position
0.2%
3/4/2026
1.19M→1.18M
Total
Net shares
−8.20K
Net value
-$163.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | F · Tax Withholding | −5.77K | $19.96 | $115.15K | 0.2% | 2.85M | 2.84M |
| Common Stock Indirect | 3/4/2026 | F · Tax Withholding | −2.43K | $19.96 | $48.54K | 0.2% | 1.19M | 1.18M |
| Total | −8.20K | -$163.69K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned6.83M
Total
6.83M indirect6.83M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 6.83M | Indirect |
| Total | 6.83M | 6.83M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported